University of Latvia and Riga East Clinical University Hospital join forces to advance cancer diagnostics in Europe

Author
University of Latvia Institute of Clinical and Preventive Medicine

November 4, 2025

medicine research

The University of Latvia (UL), within the framework of the EUCAIM (European Federation for Cancer Images) project, has signed a cooperation agreement with Riga East Clinical University Hospital to launch the prospective collection and aggregation of mammography images and related clinical data in Latvia.

csm_Zinatne_67c4d7ed43.jpg
Photo: Toms Grīnbergs, UL

This collaboration is part of an ambitious European initiative aimed at creating a federated cancer imaging data system for the development of artificial intelligence (AI) tools for early cancer diagnosis. EUCAIM will establish the most extensive data repository to date, providing secure access to cancer imaging data across Europe. This will enable the use of medical images for research and AI training without the need to transfer data outside the institutions entrusted with them by citizens.

“UL’s participation in EUCAIM is a clear example of how the academic environment can develop sustainable solutions to improve public health. In cooperation with the Eastern Hospital, we are advancing research in areas essential for public health while laying the groundwork for AI tools that will enhance cancer diagnostics in Latvia and across Europe,”
explains Kristaps Jaudzems, Dean of the UL Faculty of Medicine and Life Sciences.

“Latvia’s involvement means that our data and expertise will help develop practices that improve early detection and treatment decisions for various cancer types across Europe. Moreover, the new AI solutions developed will be adapted to Latvia’s specific context,”
says Inese Poļaka, lead researcher at the UL Institute of Clinical and Preventive Medicine (UL ICPM), which is the EUCAIM project partner in Latvia.

Cooperation model and data security

Under the agreement, Eastern Hospital will provide the necessary facilities and technical support for data acquisition, while UL researchers will prepare mammography images and related clinical data. In total, data from at least 200 mammography examinations are expected to be collected from Latvian patients, and these images will contribute to the European breast cancer imaging database.

Special attention is paid to data security – all collected data will be fully anonymized, strictly complying with personal data protection requirements.

European-level impact

The collected data will become part of a broader European initiative uniting EU member states to create the largest and highest-quality cancer imaging dataset for research purposes. Such a large-scale database will enable the development and validation of new AI tools that could revolutionize early cancer diagnosis.

“Collaboration with the Eastern Hospital not only promotes interdisciplinary teamwork but also strengthens Latvia’s contribution to one of Europe’s most significant digital health projects, positioning our country as an active participant in the innovation-driven future of medicine,”
emphasizes Professor Mārcis Leja, gastroenterologist and Director of the UL ICPM.

About the EUCAIM project

EUCAIM (European Federation for Cancer Images) is an ambitious Horizon Europe initiative focused on improving access to cancer imaging data for research and AI development. The project aims to establish a federated data infrastructure that enables the secure use of data while safeguarding patient privacy and data protection standards.

In the context of EUCAIM, a federated system means the ability to search and access cancer imaging data distributed among various institutions and data repositories across Europe, without centralizing all data in one location. For example, if a researcher searches for “breast cancer MRI scans with specific features,” the system will query all partner data centers across the EU and return aggregated results, while the data themselves remain securely stored at their original institutions.

More information:
The EUCAIM project is co-funded by the European Union’s Digital Europe Programme under grant agreement No. 1011100633.

Recommended articles

medicine biomedicīna pētniecība

National Institute of Research and Innovation: Synergy Between Chemistry and Biomedicine

The National Institute of Research and Innovation (NIRI) is a European-level life and natural sciences research centre in Latvia, established in the summer of 2026 through the merger of the Latvian Institute of Organic Synthesis (OSI) and the Latvian Biomedical Research and Study Centre (BMC). The …

National Institute of Research and Innovation

October 26, 2026

natural sciences humanities and arts medicine

AMBER HORIZONS — Upcoming Research and Academic Career Opportunities at the University of Latvia

The University of Latvia invites outstanding researchers with significant scientific achievements to explore upcoming Associate Professor opportunities within the AMBER HORIZONS programme, which is part of the Marie Skłodowska-Curie Actions initiative “Choose Europe for Science”. The Universit…

University of Latvia

October 26, 2026

public health medicine

Prevention Plays an Increasingly Important Role in Breast Cancer Treatment

October is Breast Health Awareness Month. Breast cancer is the most common malignant tumour among women in Latvia – around 1,200 women are diagnosed with it each year. Approximately 10% of breast cancer cases may be associated with inherited genetic changes (mutations). Modern genetic testing makes…

Research Latvia

October 23, 2026

research

Dace Kārkle Appointed Director of the National Institute of Research and Innovation

On 20 October 2026, Dace Kārkle, the institute’s former Acting Director and a long-standing member of the management team at the Latvian Institute of Organic Synthesis (LIOS), was appointed Director of the National Institute of Research and Innovation (NIRI). She will take up the position with imme…

The National Institute of Research and Innovation (NIRI)

October 21, 2026